We are live on ! Find out more
USNA icon

Usana Health Sciences

189 hedge funds and large institutions have $1.48B invested in Usana Health Sciences in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 68 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

109% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 22

42% more capital invested

Capital invested by funds: $1.04B → $1.48B (+$438M)

36% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 50

13% more funds holding

Funds holding: 168189 (+21)

2.81% more ownership

Funds ownership: 50.18%52.99% (+2.8%)

45% less call options, than puts

Call options by funds: $899K | Put options by funds: $1.64M

Holders
189
Holders Change
+21
Holders Change %
+12.5%
% of All Funds
4.33%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
68
Reduced
50
Closed
22
Calls
$899K
Puts
$1.64M
Net Calls
-$740K
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UFF
101
USA Financial Formulas
Michigan
$865K -$4.7K -43 -0.4%
First Trust Advisors
102
First Trust Advisors
Illinois
$863K -$549K -5,018 -40%
UBS AM
103
UBS AM
Illinois
$848K
USAA
104
United Services Automobile Association
Texas
$804K +$68.9K +630 +10%
CEP
105
Chicago Equity Partners
Illinois
$695K -$750K -6,860 -53%
SAM
106
Shell Asset Management
Netherlands
$694K -$35.8K -327 -5%
Royal Bank of Canada
107
Royal Bank of Canada
Ontario, Canada
$655K -$10.8K -99 -2%
MIM
108
MetLife Investment Management
New Jersey
$646K
HMS
109
Hanseatic Management Services
New Mexico
$635K +$602K +5,504 New
BCM
110
Bayesian Capital Management
New York
$623K +$591K +5,404 New
Bank of Montreal
111
Bank of Montreal
Ontario, Canada
$589K +$392K +3,586 +235%
VOYA Investment Management
112
VOYA Investment Management
Georgia
$571K -$31.8K -291 -6%
MAM
113
Meeder Asset Management
Ohio
$567K +$468K +4,280 +675%
TI
114
Trexquant Investment
Connecticut
$555K +$527K +4,814 New
TCOV
115
Trust Company of Vermont
Vermont
$539K -$3.61K -33 -0.7%
CANY
116
Caxton Associates (New York)
New York
$525K +$498K +4,550 New
TRCT
117
Tower Research Capital (TRC)
New York
$524K -$128K -1,169 -20%
IFS
118
Ifrah Financial Services
Arkansas
$524K +$3.28K +30 +0.7%
QT
119
Quantbot Technologies
New York
$518K +$488K +4,464 +14,400%
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
$517K +$68.2K +623 +16%
BCM
121
BlueCrest Capital Management
Jersey
$489K +$464K +4,241 New
AIMCA
122
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$473K -$3.48M -31,800 -89%
Capital Fund Management (CFM)
123
Capital Fund Management (CFM)
France
$473K +$449K +4,100 New
DTL
124
Dynamic Technology Lab
Singapore
$462K +$439K +4,013 New
Legal & General Group
125
Legal & General Group
United Kingdom
$454K -$210K -1,916 -33%

USNA Hedge Fund Activity: Q2 2018 in Review

189 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2018, worth a combined $1.48B — up 42% from $1.04B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new USNA positions and 22 closed out — a net gain of 24 holders — while 68 added to existing stakes and 50 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $51.9M. The largest seller was Fidelity Investments, cutting an estimated $80.7M.

  • 189 institutional investors held Usana Health Sciences (USNA) as of Q2 2018, up from 168 in Q1 2018.
  • Funds reported $1.48B of Usana Health Sciences stock for Q2 2018, up 42% quarter-over-quarter.
  • 46 funds opened new Usana Health Sciences positions in Q2 2018 and 22 closed out, a net change of +24 holders.
  • The largest Usana Health Sciences buyer in Q2 2018 was Acadian Asset Management, an estimated $51.9M added.
  • The largest Usana Health Sciences seller in Q2 2018 was Fidelity Investments, an estimated $80.7M sold.

Based on aggregated 13F filings for Q2 2018.